Catatonia breakthrough: blood test may predict drug response
NCT ID NCT04530734
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study looks at why some people with catatonia don't get better with the standard medicine lorazepam. Researchers will measure the drug's level in the blood after 3 days of treatment and check for genetic differences that might affect how the body processes the medicine. The goal is to find non-responders early so their treatment can be changed sooner. The study involves 100 adults with catatonia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATATONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Fontan, CHU lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.